This image shows the Spravato® (esketamine) nasal spray device, used in clinical settings to treat adults with treatment-resistant depression. The device is displayed on a clean, gradient background symbolizing the innovative and targeted nature of the treatment. Each session is supervised by healthcare providers in a REMS-certified clinic.